Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.2952 per EA under NDC 69238269301. Its NADAC has been published 87 times since Feb 5, 2025.
FDA first approved this application on Jun 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238269301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CABERGOLINEApproval Type
Generic (ANDA)
FDA Application
ANDA218618FDA Approved
6/26/2024
TE Code
AB
On Market Since
10/3/2024
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 87 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2952 per EA |
|---|---|
| All-time high | $1.6393 (Jun 11, 2025) |
| All-time low | $1.2860 (Feb 5, 2025) |
| 52-week high | $1.5270 |
| 52-week low | $1.2952 |
| Median price | $1.4462 |
| Average price | $1.4687 |
| Largest weekly change | +15.0% (Feb 19, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cabergoline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ergot Derivative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $1.2952 per EA (NDC 69238269301), effective Sep 30, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Feb 5, 2025, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.2860 (Feb 5, 2025) to a high of $1.6393 (Jun 11, 2025), with a median of $1.4462 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CABERGOLINE 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 69238269301) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.